> Analysis of Association Between the Effects of Methylphenidate and DRD4 Gene Polymorphisms in Patients with Attention Deficit Hyperactivity Disorder

[[amiri2021.pdf#page=1&selection=6,0,11,22|amiri2021, page 1]]

> DRD4 genotyping may differentiate symptoms of attention-deficit/hyperactivity disorder and sluggish cognitive tempo

[[bolat2020.pdf#page=1&selection=2,0,6,15|bolat2020, page 1]]

